Riding the Trend or Protecting Profits | Globus Medical Inc. (GMED) – News Heater
Home  »  Trending   »  Riding the Trend or Protecting Profits | Globus Me...

Riding the Trend or Protecting Profits | Globus Medical Inc. (GMED)

Globus Medical Inc. (NYSE:GMED) went up by 5.48% from its latest closing price compared to the recent 1-year high of $84.23. The company’s stock price has collected 2.96% of gains in the last five trading sessions.

Is It Worth Investing in Globus Medical Inc. (NYSE :GMED) Right Now?

Globus Medical Inc. (NYSE:GMED) scored a price-to-earnings ratio above its average ratio, recording 42.02 x from its present earnings ratio. Plus, the 36-month beta value for GMED is at 1.18. Opinions of the stock are interesting as 9 analysts out of 14 who provided ratings for Globus Medical Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 4 rated it as “hold,” and 0 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


The average price from analysts is $74.08, which is $18.72 above the current price. GMED currently public float of 78.49M and currently shorts hold a 5.75% ratio of that float. Today, the average trading volume of GMED was 862.06K shares.

GMED’s Market Performance

GMED stocks went up by 2.96% for the week, with a monthly drop of -11.65% and a quarterly performance of -16.99%, while its annual performance rate touched -23.17%. The volatility ratio for the week stands at 4.32% while the volatility levels for the past 30 days are set at 3.18% for Globus Medical Inc. The simple moving average for the period of the last 20 days is -6.52% for GMED stocks with a simple moving average of -19.00% for the last 200 days.

Analysts’ Opinion of GMED

Many brokerage firms have already submitted their reports for GMED stocks, with Truist repeating the rating for GMED by listing it as a “Buy.” The predicted price for GMED in the upcoming period, according to Truist is $91 based on the research report published on April 13th of the current year 2022.

Wells Fargo, on the other hand, stated in their research note that they expect to see GMED reach a price target of $80. The rating they have provided for GMED stocks is “Overweight” according to the report published on March 28th, 2022.

Piper Sandler gave a rating of “Overweight” to GMED, setting the target price at $88 in the report published on January 04th of the current year.

GMED Trading at -12.97% from the 50-Day Moving Average

After a stumble in the market that brought GMED to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -31.90% of loss for the given period.

Volatility was left at 3.18%, however, over the last 30 days, the volatility rate increased by 4.32%, as shares sank -13.09% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -24.87% lower at present.

During the last 5 trading sessions, GMED rose by +2.96%, which changed the moving average for the period of 200-days by -31.46% in comparison to the 20-day moving average, which settled at $60.93. In addition, Globus Medical Inc. saw -20.55% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at GMED starting from Davidar David D, who sale 31,500 shares at the price of $78.03 back on Apr 19. After this action, Davidar David D now owns 601,275 shares of Globus Medical Inc., valued at $2,458,071 using the latest closing price.

Huller Kelly, the SVP, GC, Corporate Secretary of Globus Medical Inc., sale 2,500 shares at $75.58 during a trade that took place back on Apr 08, which means that Huller Kelly is holding 0 shares at $188,962 based on the most recent closing price.

Stock Fundamentals for GMED

Current profitability levels for the company are sitting at:

  • +20.34 for the present operating margin
  • +73.10 for the gross margin

The net margin for Globus Medical Inc. stands at +15.57. Equity return is now at value 8.20, with 7.40 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 6.17.

Is Kimberly-Clark Corporation (KMB) a Keeper?

Kimberly-Clark Corporation (NYSE:KMB) went up by 3.54% from its latest closing price compared to the recent 1-year high of $145.79. The company’s stock price has